Indian Pharma Industry: An Investment Opportunity - Expected to grow over 15 per cent per annum between 2015 and 2020, Pharmaceutical Unit (Tablet, Capsules & Syrup) Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends

Wednesday, February 22, 2017

facebook twitter Bookmark and Share

Indian Pharma Industry: An Investment Opportunity - Expected to grow over 15 per cent per annum between 2015 and 2020, Pharmaceutical Unit (Tablet, Capsules & Syrup) Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics, Production Schedule, Working Capital Requirement, Plant Layout, Process Flow Sheet, Cost of Project, Projected Balance Sheets, Profitability Ratios, Break Even Analysis


The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value. India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume. India enjoys an important position in the global pharmaceuticals sector.

The Department of Pharmaceuticals has a Vision for the development of the IndianPharmaceutical Industry.  This Vision is –  

“To make India the Largest Global Provider of Quality Medicines at Reasonable Prices.”

The Vision is to be achieved as per the following Mission:

·         Develop Human Resources for Pharmaceutical Industry and Drug Research and Development

·         Promote Publicā€Private Partnership for development of pharmaceuticals Industry

·         Promote Pharma Brand India through International Cooperation

·         Promote environmentally sustainable development of Pharmaceutical Industry

·         Enable availability, accessibility and affordability of drugs  

Pharmaceutical companies in India both Indian and foreign, manufacture bulk drugs in several therapeutic categories and the industry has facilities to manufacture various types of dosage namely capsule, tablets, injectable, orals, and liquids. The industry today can boast of producing the entire range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations.

According to the Federation of Indian Chambers of Commerce and Industry (FICCI), another apex industry association, there are some 6,000 firms engaged in the sector. In terms of revenue generation, there are 100 big companies (including subsidiaries of MNCs) each with sales of at least USD 650,000, 200 medium size companies with sales ranging between USD 210,400 and USD 650,000; and 5700 small companies with sales of less than USD 210,400. Because many of these companies focus on producing similar generic or same drugs, the industry is characterized by fierce competition and high volumes, razor-thin profit margins, overcapacity, and declining prices.

The growth has been driven by many factors, such as legislative reforms, growth in contract manufacturing and outsourcing, value added foreign acquisitions and joint ventures and India's acu-men and expertise in reverse engineering of patented drug molecules. India has, in the meantime, been trying to comply with the World Trade Organization's Trade Related Intellectual Property Agreement (TRIPs) obligations.

The Indian pharma industry, which is expected to grow over 15 per cent per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 per cent between the same period!. The market is expected to grow to US$ 55 billion by 2020.

Few Indian Major Players are as under

  • A Tosh & Sons (India) Ltd.
  • Aarti Industries Ltd.
  • Agio Pharmaceuticals Ltd.
  • Alintosch Pharmaceuticals Ltd.
  • Anil Bioplus Ltd.
  • Anil Starch Products Ltd.
  • Astrix Laboratories Ltd.
  • B A & Brothers (Eastern) Ltd.
  • Caldern Pharmaceuticals Ltd.
  • ExpicorPharma Pvt. Ltd.
  • Fem Care Pharma Ltd.
  • German Remedies Ltd.
  • HiranOrgochem Ltd.
  • Kedia Chemicals Inds. Ltd.
  • KunshanRotam Reddy Pharmaceutical Co. Ltd.
  • Larite Industries Ltd.
  • Lyka Labs Ltd.
  • Max Healthcare Institute Ltd.
  • Midas Pharmasec Ltd.
  • N G L Fine-Chem Ltd.
  • Norris Medicines Ltd.
  • Sanofi India Ltd.
  • Sayaji Industries Ltd.
  • Stellar Exports Ltd.
  • Suyash Laboratories Ltd.
  • United Breweries (Holdings) Ltd.
  • Vellanova Pharmaceuticals Ltd.
  • Vera Pharma Ltd.
  • Vivo Bio Tech Ltd.
  • Winmac Laboratories Ltd.
  • Yogi Pharmacy Ltd.

See more


Contact us

Niir Project Consultancy Services

106-E, Kamla Nagar, Opp. Spark Mall,

New Delhi-110007, India.

Email: [email protected], [email protected]     

Tel: +91-11-23843955, 23845654, 23845886, 8800733955

Mobile: +91-9811043595

Fax: +91-11-23841561

Website : ,     

blog comments powered by Disqus

About NIIR

Hide ^

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Section of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top

Products & Services


Contact Us

My Account


Payment Options

  • Credit Cards
  • Debit Cards
  • PayPal
  • Net Banking - (All Major Indian Banks)

We Process

  • Cards

Google Search

Search Blog